Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
A number of firms have modified their ratings and price targets on shares of Nuwellis (NASDAQ: NUWE) recently: 4/6/2022 – Nuwellis was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $1.25 price target on the stock. According to Zacks, “Nuwellis Inc. is a medical […]
Nuwellis (NASDAQ:NUWE – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Wednesday, Zacks.com reports. The brokerage presently has a $1.25 target price on the stock. Zacks Investment Research‘s price target would suggest a potential upside of 25.00% from the stock’s previous […]
Movano (NASDAQ:MOVE – Get Rating) and Nuwellis (NASDAQ:NUWE – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership and profitability. Earnings & Valuation This table compares Movano and Nuwellis’ top-line revenue, […]
Nuwellis (NASDAQ:NUWE – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday, Zacks.com reports. According to Zacks, “Nuwellis Inc. is a medical device company. It is focused on developing, manufacturing and commercializing the Aquadex SmartFlow(R) System for […]